This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Yonsei University. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Il Kwon: Innovator in Vascular Disease Treatment
Introduction
Il Kwon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of vascular diseases. With a total of 2 patents to his name, Kwon's work focuses on innovative methods for addressing thrombotic conditions.
Latest Patents
Kwon's latest patents include a method for treating vascular stenosis or occlusive disease due to thrombi by administering a saxatilin-fc fusion protein. This invention relates to a saxatilin derivative that has an increased half-life and demonstrates thrombolytic ability similar to that of saxatilin, the mother protein. The saxatilin derivative efficiently dissolves blood clots in animal models and is particularly useful for treating various angiostenosis or occlusive diseases, including cerebrovascular and cardiovascular diseases.
Another notable patent is a composition for dissolving thrombi, which comprises a peptide featuring the Arg-Gly-Asp motif. This pharmaceutical composition effectively treats stenotic or occlusive vascular diseases and employs a unique method of targeting integrin within the thrombus. The compositions developed by Kwon not only break down thrombi but also possess nerve-protecting functions, ensuring effective treatment without the risk of restenosis.
Career Highlights
Il Kwon is affiliated with Yonsei University, where he continues to advance his research and innovations in the medical field. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from vascular diseases.
Collaborations
Kwon collaborates with notable colleagues, including Sung Yu Hong and Ji Hoe Heo, to further enhance the impact of his research and inventions.
Conclusion
Il Kwon's contributions to the field of vascular disease treatment through his innovative patents highlight his role as a leading inventor. His work promises to significantly improve therapeutic options for patients with thrombotic conditions.